Attorney General Paxton argues that the company’s programs and offerings were essentially bribes and resulted in millions in ...

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...

Oikos Fusion offers a nutrient-dense dairy drink designed to support muscle mass and digestive health during weight loss ...

The collaboration will fund early-stage clinical development of SB-4826, CIT’s first-in-class SUMO E1 inhibitor, for patients ...

Insurance companies are increasingly restricting coverage for GLP-1 medications, impacting patient access and affordability.

Monica Seles partners with argenx to raise awareness for Myasthenia Gravis, sharing her journey to empower and support those affected by the condition.

Commerce Secretary Howard Lutnick originally stated the investigation should be completed by mid-June. However, a new report from Reuters says that any official announcement on tariffs is still weeks ...

Bayer partners with Kumquat Biosciences to advance a promising Kras G12D cancer treatment, aiming to address critical unmet ...

Cardinal Health's Specialty Alliance will acquire Solaris Health for $1.9 billion, enhancing its urology capabilities. The ...

Brinsupri is a first-in-class DPP1 inhibitor that has been found to inhibit activation of neutrophil enzymes that drive chronic airway inflammation in non-cystic fibrosis bronchiectasis.

The journal is standing by the study, which looked into the safety of vaccines that have aluminum ingredients.

Results from the Phase III NEPTUNUS-1 (NCT05350072) and NEPTUNUS-2 (NCT05349214) trials demonstrated that ianalumab ...